27S Stock Overview
Through its subsidiaries, engages in the operation of food and drug stores in the United States. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
+ 1 more risk
Albertsons Companies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$28.45 |
52 Week High | US$33.80 |
52 Week Low | US$23.60 |
Beta | 0.33 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 4.60% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 96.83% |
Recent News & Updates
Recent updates
Shareholder Returns
27S | DE Consumer Retailing | DE Market | |
---|---|---|---|
7D | 0% | -2.7% | -0.02% |
1Y | 4.6% | -14.1% | 8.2% |
Return vs Industry: 27S exceeded the German Consumer Retailing industry which returned -13% over the past year.
Return vs Market: 27S matched the German Market which returned 4.7% over the past year.
Price Volatility
27S volatility | |
---|---|
27S Average Weekly Movement | n/a |
Consumer Retailing Industry Average Movement | 6.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 27S has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 27S's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1860 | 195,750 | Vivek Sankaran | www.albertsonscompanies.com |
Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company’s food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores.
Albertsons Companies, Inc. Fundamentals Summary
27S fundamental statistics | |
---|---|
Market cap | €11.07b |
Earnings (TTM) | €1.43b |
Revenue (TTM) | €74.75b |
7.7x
P/E Ratio0.1x
P/S RatioIs 27S overvalued?
See Fair Value and valuation analysisEarnings & Revenue
27S income statement (TTM) | |
---|---|
Revenue | US$75.34b |
Cost of Revenue | US$53.58b |
Gross Profit | US$21.77b |
Other Expenses | US$20.32b |
Earnings | US$1.44b |
Last Reported Earnings
Sep 10, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 2.70 |
Gross Margin | 28.89% |
Net Profit Margin | 1.91% |
Debt/Equity Ratio | 147.9% |
How did 27S perform over the long term?
See historical performance and comparison